ARDSLEY ADVISORY PARTNERS LP Q4 2017 Filing
Filed February 14, 2018
Portfolio Value
$823.0M
Holdings
137
Report Date
Q4 2017
Filing Type
13F-HR
All Holdings (137 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | EX9EXELIXIS INC | 12,500 | $380K | 0.05% | |
| 102 | VRTXVERTEX PHARMACEUTICALS INC | 2,500 | $375K | 0.05% | |
| 103 | WBAWALGREENS BOOTS ALLIANCE INC | 5,000 | $363K | 0.04% | |
| 104 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 100,000 | $350K | 0.04% | |
| 105 | EGHT8X8 INC NEW | 24,000 | $338K | 0.04% | |
| 106 | RGNXREGENXBIO INC | 10,000 | $334K | 0.04% | |
| 107 | NBISYANDEX N V | 10,000 | $328K | 0.04% | |
| 108 | —POLARITYTE INC | 14,100 | $327K | 0.04% | |
| 109 | TEAMATLASSIAN CORP PLC | 7,000 | $319K | 0.04% | |
| 110 | ATRCATRICURE INC | 17,500 | $319K | 0.04% | |
| 111 | ALDXALDEYRA THERAPEUTICS INC | 45,000 | $306K | 0.04% | |
| 112 | —FINISAR CORP | 15,000 | $305K | 0.04% | |
| 113 | —CYPRESS SEMICONDUCTOR CORP | 20,000 | $305K | 0.04% | |
| 114 | —AZURRX BIOPHARMA INC | 82,500 | $300K | 0.04% | |
| 115 | RUNSUNRUN INC | 50,000 | $295K | 0.04% | Call |
| 116 | NVDANVIDIA CORP | 1,500 | $290K | 0.04% | |
| 117 | BDQMALBIREO PHARMA INC | 11,300 | $289K | 0.04% | |
| 118 | —DERMIRA INC | 10,000 | $278K | 0.03% | |
| 119 | CERSCERUS CORP | 80,000 | $270K | 0.03% | |
| 120 | —BIOSCRIP INC | 90,000 | $262K | 0.03% | |
| 121 | —AKCEA THERAPEUTICS INC | 15,000 | $260K | 0.03% | |
| 122 | AMBAAMBARELLA INC | 4,000 | $235K | 0.03% | |
| 123 | RPDRAPID7 INC | 12,000 | $224K | 0.03% | |
| 124 | —ACER THERAPEUTICS INC | 15,300 | $212K | 0.03% | |
| 125 | —IDERA PHARMACEUTICALS INC | 100,000 | $211K | 0.03% | |
| 126 | GYRECATALYST BIOSCIENCES INC | 15,000 | $205K | 0.02% | |
| 127 | —NUVECTRA CORP | 22,095 | $171K | 0.02% | |
| 128 | —APOLLO ENDOSURGERY INC | 28,800 | $161K | 0.02% | |
| 129 | PSTGPURE STORAGE INC | 10,000 | $159K | 0.02% | |
| 130 | CDNACAREDX INC | 20,000 | $147K | 0.02% | |
| 131 | —OXFORD IMMUNOTEC GLOBAL PLC | 10,000 | $140K | 0.02% | |
| 132 | RUBIEURRUBICON PROJ INC | 70,000 | $131K | 0.02% | |
| 133 | —NANTKWEST INC | 25,000 | $112K | 0.01% | |
| 134 | —CASCADIAN THERAPEUTICS INC | 25,000 | $93K | 0.01% | |
| 135 | —IMPRIMIS PHARMACEUTICALS INC | 50,000 | $85K | 0.01% | |
| 136 | —LIPOCINE INC NEW | 10,000 | $34K | 0.00% | |
| 137 | —CONTRAFECT CORP | 15,000 | $15K | 0.00% |
PreviousPage 2 of 2